Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.59 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.59 |
| ▸ | ACHE | P22303 | 4/20 | 0.44 |
| ▸ | CNR1 | P21554 | 2/20 | 0.40 |
| ▸ | CNR2 | P34972 | 2/20 | 0.40 |
| ▸ | PARP1 | P09874 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | KIF11 | P52732 | 4/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.39 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.38 |
| ▸ | HTR3B | O95264 | 1/20 | 0.38 |
| ▸ | HTR3A | P46098 | 1/20 | 0.38 |
| ▸ | HTR3D | Q70Z44 | 1/20 | 0.38 |
| ▸ | HTR3C | Q8WXA8 | 1/20 | 0.38 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2969176 | 0.87 | ALDH1A1 (0.70) | ALDH1A1ALOX15ACHECYP3A4MAPK1 | |
| SCHEMBL24841066 | 0.84 | ALDH1A1 (0.47) | ALDH1A1ALOX15ACHECNR1CNR2 | |
| SCHEMBL12032158 | 0.81 | ACHE (0.46) | ALDH1A1ALOX15ACHECNR1CNR2 | |
| SCHEMBL2969906 | 0.79 | ALDH1A1 (0.59) | ALDH1A1ALOX15ACHEKCNH2MAPK1 | |
| SCHEMBL7718229 | 0.79 | ALDH1A1 (0.59) | ALDH1A1ALOX15ACHELMNAKIF11 | |
| SCHEMBL29472192 | 0.79 | ALDH1A1 (0.59) | ALDH1A1ALOX15ACHELMNAKIF11 | |
| SCHEMBL10929633 | 0.78 | ALDH1A1 (0.50) | ALDH1A1ALOX15ACHECYP2C9CYP2C19 | |
| SCHEMBL11572922 | 0.78 | ALDH1A1 (0.50) | ALDH1A1ALOX15ACHECNR1CNR2 | |
| SCHEMBL11427450 | 0.78 | MAPK1 (0.68) | ALDH1A1ALOX15ACHECNR1CNR2 | |
| SCHEMBL29472201 | 0.78 | ALDH1A1 (0.57) | ALDH1A1ALOX15CYP3A4MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-54128536-A | — | — | None | — | — | JP | disclosed |
| US-12043683-B2 | Dental materials based on redox systems with oligomeric cumene hydroperoxide derivatives | IVOCLAR VIVADENT AG (LI) | 2024-07-23 | — | — | US | disclosed |
| EP-4094748-B1 | DENTAL MATERIALS BASED ON REDOX SYSTEMS WITH OLIGOMERIC CUMOLHYDROPEROXIDE DERIVATIVES | IVOCLAR VIVADENT AG (LI) | 2023-09-20 | — | — | EP | disclosed |
| EP-0879224-B2 | NOVEL POLY(MONOPEROXYCARBONATES) | ARKEMA INC (US) | 2013-12-25 | — | — | EP | disclosed |
| EP-1382596-B1 | Novel poly (monoperoxycarbonates) | ARKEMA INC (US) | 2007-02-14 | — | — | EP | disclosed |
| EP-1382596-A1 | Novel poly (monoperoxycarbonates) | Atofina Chemicals, Inc. (US) | 2004-01-21 | — | — | EP | disclosed |
| EP-0879224-B1 | NOVEL POLY(MONOPEROXYCARBONATES) | ATOFINA CHEM INC (US) | 2003-10-22 | — | — | EP | disclosed |
| EP-0879224-A4 | NOVEL POLY(MONOPEROXYCARBONATES) | ATOCHEM NORTH AMERICA ELF (US) | 1999-05-26 | — | — | EP | disclosed |
| EP-0879224-A1 | NOVEL POLY(MONOPEROXYCARBONATES) | ELF ATOCHEM NORTH AMERICA, INC. (US) | 1998-11-25 | — | — | EP | disclosed |
| US-5760149-A | POLYMERIZATION INITIATORS, CURING AGENTS | ELF ATOCHEM NORTH AMERICA, INC. (US) | 1998-06-02 | — | — | US | disclosed |
| WO-1998007684-A1 | NOVEL POLY(MONOPEROXYCARBONATES) | ELF ATOCHEM NORTH AMERICA, INC. (US) | 1998-02-26 | — | — | WO | disclosed |
| JP-S54128536-A | ALPHA,ALPHA-DIMETHYLBENZYL(ALPHA,ALPHA-DIMETHYL-M-METHYLBENZYL)PEROXIDE, ITS USE AND ITS PREPARATION | MITSUI PETROCHEM IND LTD | 1979-10-05 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12043683-B2 | Dental materials based on redox systems with oligomeric cumene hydroperoxide derivatives | CBR3, NR1H3, NR1I3 | ALDH1A1 3641/4885ALOX15 309/4885ACHE 3288/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.